Rocket Pharmaceuticals
RCKT
RCKT
194 hedge funds and large institutions have $2.69B invested in Rocket Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 68 increasing their positions, 65 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
11% more funds holding
Funds holding: 175 → 194 (+19)
5% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 65
11.62% less ownership
Funds ownership: 111.02% → 99.4% (-12%)
Holders
194
Holding in Top 10
8
Calls
$33.1M
Puts
$12.7M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$25.3M | |
| 3 | +$24.5M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$13.8M |
| 5 |
Morgan Stanley
New York
|
+$13.3M |
Top Sellers
| 1 | -$47.8M | |
| 2 | -$28.5M | |
| 3 | -$21M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$12.4M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$12.2M |